These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 32893950)

  • 21. Peripheral Blood Lymphocyte-to-Monocyte Ratio Predicts Mortality in Patients with HBV-Related Decompensated Cirrhosis.
    Qi X
    Clin Lab; 2019 Jan; 65(1):. PubMed ID: 30775885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Usefulness of International Normalized Ratio to Albumin Ratio for Evaluation of Mortality in Hepatitis B Virus-Associated Decompensated Cirrhosis.
    Cai M; Han Z; He X; Zhang J
    Biomed Res Int; 2021; 2021():6664574. PubMed ID: 34055994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in Red Blood Cell Distribution Width is Associated with Liver Function Parameters and Prognosis in Patients with Chronic HBV Liver Disease.
    Kai Y; Zishu G; Shihe G; Yufeng G; Qiang Z
    Clin Lab; 2016 Nov; 62(11):2197-2202. PubMed ID: 28164679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High Mean Platelet Volume Is Associated with Worse Outcomes in Patients with HBV-Related Decompensated Cirrhosis.
    Ma Y; Quan W; Zhu H
    Ann Clin Lab Sci; 2018 Sep; 48(5):639-645. PubMed ID: 30373870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. D-Dimer-to-Albumin Ratio: A Novel Indicator to Predict Poor Outcomes in Patients with HBV-Associated Decompensated Cirrhosis.
    Sun L; Ding P; Mao W; Wu J
    Biomed Res Int; 2022; 2022():9062383. PubMed ID: 36147636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. D-dimer-to-platelet count ratio as a novel indicator for predicting prognosis in HBV-related decompensated cirrhosis.
    He X; Ding Q
    Heliyon; 2024 Mar; 10(5):e26585. PubMed ID: 38434313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the ability of the PDD-ICG clearance test, CTP, MELD, and MELD-Na to predict short-term and medium-term mortality in patients with decompensated hepatitis B cirrhosis.
    Cheng XP; Zhao J; Chen Y; Meng FK; Xu B; Yu HW; Meng QH; Liu YM; Zhang SB; Meng S; Zhang JY; Zhang JY; Duan ZP; Zheng SJ
    Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):444-8. PubMed ID: 26649802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver transplantation for hepatitis B virus: Decreasing indication and changing trends.
    Al-Hamoudi W; Elsiesy H; Bendahmash A; Al-Masri N; Ali S; Allam N; Al Sofayan M; Al Bahili H; Al Sebayel M; Broering D; Saab S; Abaalkhail F
    World J Gastroenterol; 2015 Jul; 21(26):8140-7. PubMed ID: 26185387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum Cystatin C Predicts Mortality in HBV-Related Decompensated Cirrhosis.
    Wu J; Wu Q; Wu M; Mao W
    Biomed Res Int; 2019; 2019():7272045. PubMed ID: 30949507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The C-Reactive Protein/Albumin Ratio as a Predictor of Mortality in Patients with HBV-Related Decompensated Cirrhosis.
    Wang CJ; Wu JP; Zhou WQ; Mao WL; Huang HB
    Clin Lab; 2019 Aug; 65(8):. PubMed ID: 31414767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel Marker for Predicting Prognosis in Hepatitis B Virus-Associated Decompensated Cirrhosis: Monocyte-To-Albumin Ratio.
    Yuan M; Mao WE; He X; Zhang Q
    Clin Lab; 2023 Oct; 69(10):. PubMed ID: 37844048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Albumin-Bilirubin Score Predicts Short-Term Mortality in Patients with Hepatitis B Virus-Related Decompensated Cirrhosis.
    Qi XT
    Clin Lab; 2018 May; 64(5):777-783. PubMed ID: 29739046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anemia Predicts Poor Outcomes in Patients with HBV-Related Decompensated Cirrhosis.
    Cai M; Yang N; Lin S; Ye B; Chen H; Mao WL
    Clin Lab; 2021 Mar; 67(3):. PubMed ID: 33739043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum C-reactive protein predicts early mortality in hospitalized patients with HBV-related decompensated cirrhosis.
    Zhu S; Waili Y; Qi X; Chen Y; Lou Y; Chen B
    Medicine (Baltimore); 2017 Jan; 96(4):e5988. PubMed ID: 28121954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Globulin-platelet model predicts minimal fibrosis and cirrhosis in chronic hepatitis B virus infected patients.
    Liu XD; Wu JL; Liang J; Zhang T; Sheng QS
    World J Gastroenterol; 2012 Jun; 18(22):2784-92. PubMed ID: 22719186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Value of Red Cell Distribution Width in Assessing the Severity of Hepatitis B Virus-Related Decompensated Cirrhosis.
    Zhang M; Chen S; Zhu X; Huang A; Lan F; Chen H; Li S; Qin X
    Clin Lab; 2017 Sep; 63(9):1467-1474. PubMed ID: 28879721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of entecavir and lamivudine for hepatitis B decompensated cirrhosis: meta-analysis.
    Ye XG; Su QM
    World J Gastroenterol; 2013 Oct; 19(39):6665-78. PubMed ID: 24151397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of combined therapy in patients with hepatitis B virus-related decompensated cirrhosis.
    Lv GC; Yao JM; Yang YD; Zheng L; Sheng JF; Chen Y; Li LJ
    World J Gastroenterol; 2013 Jun; 19(22):3481-6. PubMed ID: 23801842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Red cell distribution width-to-albumin ratio is a predictor of survival in hepatitis B virus-associated decompensated cirrhosis.
    Mao W; Yuan M; He X; Zhang Q
    Lab Med; 2024 Mar; 55(2):127-131. PubMed ID: 37289932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High red cell distribution width-to-platelet ratio indicates adverse outcomes for hepatitis B virus-associated decompensated cirrhosis.
    Zhang Q; Mao W; He X; Yuan M
    Biomark Med; 2023 Feb; 17(4):189-196. PubMed ID: 37158064
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.